Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn?s Disease
What is the goal of the study?
With the CAMEO study we will focus on patients receiving optimized anti-TNF therapy within 180 days of diagnosis by utilization of frequent drug level monitoring and pharmacokinetic based dosage guidance, formalizing intestinal re-evaluation at standardized time-points with central adjudication, and fully characterizing the biologic profile of all participants.
Who can participate in the study?
Please contact the study team listed below to learn more.